These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 18218340)

  • 21. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.
    Cusi K
    Clin Liver Dis; 2009 Nov; 13(4):545-63. PubMed ID: 19818304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus.
    Choi J; Ou JH
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G847-51. PubMed ID: 16603728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial glutathione: hepatocellular survival-death switch.
    Garcia-Ruiz C; Fernandez-Checa JC
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S3-6. PubMed ID: 16958667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis and therapy in NASH].
    Tokushige K
    Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-alcoholic steatohepatitis: review of a growing medical problem.
    Te Sligte K; Bourass I; Sels JP; Driessen A; Stockbrugger RW; Koek GH
    Eur J Intern Med; 2004 Feb; 15(1):10-21. PubMed ID: 15066643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Serfaty L; Lemoine M
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.
    Bradbury MW
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G194-8. PubMed ID: 16407588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of oxidative stress in non-alcoholic steatohepatitis.
    Koek GH; Liedorp PR; Bast A
    Clin Chim Acta; 2011 Jul; 412(15-16):1297-305. PubMed ID: 21514287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathogenic molecular mechanisms in non-alcoholic steatohepatitis].
    Alvarez-Martínez HE; Montaño-Estrada LF; Hernández-Cruz P; Pérez-Campos E
    Rev Gastroenterol Mex; 2004; 69(3):176-83. PubMed ID: 15759791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adipokines and liver fibrosis.
    Marra F; Aleffi S; Bertolani C; Petrai I; Vizzutti F
    Eur Rev Med Pharmacol Sci; 2005; 9(5):279-84. PubMed ID: 16231590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
    Petta S; Muratore C; Craxì A
    Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic Steatohepatitis.
    Suzuki A; Diehl AM
    Annu Rev Med; 2017 Jan; 68():85-98. PubMed ID: 27732787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex.
    De Minicis S; Brenner DA
    J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S98-103. PubMed ID: 18336675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of non-alcoholic steatohepatitis.
    McClain CJ; Mokshagundam SP; Barve SS; Song Z; Hill DB; Chen T; Deaciuc I
    Alcohol; 2004 Aug; 34(1):67-79. PubMed ID: 15670668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NASH and HCC.
    Page JM; Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adiponectin and alcoholic fatty liver disease.
    Rogers CQ; Ajmo JM; You M
    IUBMB Life; 2008 Dec; 60(12):790-7. PubMed ID: 18709650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial involvement in non-alcoholic steatohepatitis.
    Serviddio G; Sastre J; Bellanti F; Viña J; Vendemiale G; Altomare E
    Mol Aspects Med; 2008; 29(1-2):22-35. PubMed ID: 18061659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: diagnosis and treatment of non-alcoholic fatty liver disease.
    Oh MK; Winn J; Poordad F
    Aliment Pharmacol Ther; 2008 Sep; 28(5):503-22. PubMed ID: 18532991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
    Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
    Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
    Anderson N; Borlak J
    Pharmacol Rev; 2008 Sep; 60(3):311-57. PubMed ID: 18922966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.